Advanced testing covered by NHI to benefit 20,000 cancer patients a year

Around 20,000 cancer patients per year will benefit from more advanced Next Generation Sequencing (NGS) testing included in the coverage provided by the National Health Insurance (NHI) system, the National Health Research Institutes (NHRI) said Tuesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)